Medication info
Telmisartan 80 mg Tablets

Telmisartan 80 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Green Cross Corp.
Appearance
White or off-white oval tablets
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201003094 · Notified 2010.04.27 · Insurance code 644501750

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. When this medicine is administered concomitantly with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Green Cross Corp.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of organ damage
  • high-risk diabetes
  • myocardial infarction
View approved original text

This medication helps control blood pressure in patients with essential hypertension. It also reduces the likelihood of developing cardiovascular diseases in high-risk patients aged 55 and older. Specifically, it is used to lower the risk of myocardial infarction, stroke, and death due to cardiovascular diseases in those with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, or those with organ damage due to diabetes. This efficacy significantly contributes to improving the cardiovascular health of patients.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. When this medicine is administered concomitantly with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication may cause serious harm to both the fetus and newborn during pregnancy, so discontinuation is necessary if pregnancy is confirmed. It should not be used in women who are pregnant or breastfeeding, patients with severe liver impairment, a history of certain angioedema, or those with diabetes or severe kidney impairment. Elderly patients or those with hyperkalemia, liver disease, cardiovascular disease, gastrointestinal disorders, or renovascular hypertension should use this medication cautiously and monitor their condition carefully. During treatment, various adverse reactions such as blood pressure reduction, hyperkalemia, renal dysfunction, angioedema, liver dysfunction, interstitial pneumonia, and rhabdomyolysis may occur, and any symptoms should be discussed with a physician immediately. Patients with impaired renal function should have their serum potassium and creatinine levels monitored regularly, and any deficiencies in blood volume or sodium should be corrected before administration to prevent symptoms of hypotension. When used with other antihypertensive medications or certain drugs, interactions may occur, so patients should inform their physician or pharmacist and monitor carefully. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers are advised to discontinue breastfeeding while taking this medication. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established. In elderly patients, caution should be exercised to avoid excessive blood pressure reduction, and consideration should be given to the risk of dizziness or fainting when driving or operating hazardous machinery. In the case of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute renal failure may occur, requiring immediate emergency treatment and frequent checks of blood pressure and blood tests.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 105 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • vertigo
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • dysgeusia
  • abnormal liver function
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • pain in extremities
  • tendon pain
  • acute renal failure
  • kidney impairment
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • weakness
  • hunger
  • cold sweat
  • hand tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • cough
  • abnormal chest X-ray
  • rhabdomyolysis
  • myalgia
  • weakness
  • elevated myoglobin in blood and urine
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • edema
  • decreased libido
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White or off-white oval tablets

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.